Skip to main content
Clinical Trials/NCT04917640
NCT04917640
Withdrawn
Not Applicable

Accelerated Partial Breast Irradiation (PBI) With Stereotactic Body Radiation Therapy (SBRT) or Intensity Modulated Radiation Therapy (IMRT)

GenesisCare USA1 site in 1 countryJune 2021
ConditionsBreast Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
GenesisCare USA
Locations
1
Primary Endpoint
Number of participants with treatment and toxicity-related adverse events as assessed by CTCAE v4.0".
Status
Withdrawn
Last Updated
4 years ago

Overview

Brief Summary

This is a registry study that will be used to evaluate external beam radiation therapy methods for the accelerated treatment of breast cancer. Patients are being asked to take part in this registry because they have breast cancer and desire treatment with accelerated partial breast irradiation to be delivered by external beam methods.

Registry
clinicaltrials.gov
Start Date
June 2021
End Date
December 2024
Last Updated
4 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
GenesisCare USA
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Greater than or equal to 50 years old Low to intermediate DCIS Tumor size \< or = to 2cm

Exclusion Criteria

  • BRCA positive Lobular histology Angiolymphatic invasion

Outcomes

Primary Outcomes

Number of participants with treatment and toxicity-related adverse events as assessed by CTCAE v4.0".

Time Frame: Through study completion, an average of 12 months

Toxicity will be assessed using the CTCAEv4.0 and recorded.

Secondary Outcomes

  • Number of participants with ipsilateral breast recurrence(Through study completion, an average of 12 months)

Study Sites (1)

Loading locations...

Similar Trials